Charles J. Dockendorff

Charles J. Dockendorff (board member) discloses dealings in 4 companies, chiefly Hologic Inc, Boston Scientific Corp and Keysight Technologies, Inc. We count 29 filings; the first trade dates from 12 February 2016 and the latest from 7 April 2026.

The open-market side counts 1 purchase alongside 3 sales for €1.9M. No amount is published for 1 filing, which the totals therefore leave out. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 19 share grants and 1 option exercise.

The latest filing, published on 9 April 2026, reports a transaction in Hologic Inc. The most recent open-market purchase was published on 16 February 2016, 3,896 days ago. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.